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sion (180/130 mm Hg) and chronic renal failure (serum creatinine 3.1
mgldl). Protein excretion, 3 g/day, was associated with microscopic
hematuria. Audiometric testing was normal, and ophthalmic examina-
tion did not reveal lenticonus or perimacular changes.
The patient belongs to a kindred with Alport's syndrome (Fig. 2). His
father, who is 63 years of age, has undergone hemodialysis for 10 years.
He has severe perceptive deafness. Three males and one female in the
kindred died from renal failure. One cousin (IV 1, Fig. 2) had a renal
transplant in 1972 at age 39 and has stable renal function at present.
Renal biopsy in another affected cousin (IV 2, Fig. 2) disclosed
characteristic ultrastructural changes of Alport's syndrome in the
glomerular basement membrane.
Now, one year later, the patient's blood pressure is well controlled
with 200 mg of metoprolol per day, and serum creatinine is 4.5 mgldl.
Discussion
Case presentations
Patient 1. A 30-year-old woman had been referred to the Department
of Nephrology of Hôpital Necker at age 19 for evaluation of proteinuria
and microscopic hematuria. At that time, blood pressure was 110/60
mm Hg and urinary protein excretion ranged from 2.7 to 5.7 g/24 hr.
Urine erythrocyte count was 500,000/mm. Serum protein and albumin
levels were 5.7 and 3.1 g/dl, respectively. Creatinine clearance was 95
mI/mm and serum creatinine 0.9 mg/dl. Percutaneous renal biopsy
showed mild interstitial fibrosis associated with ischemic glomerular
changes, but no foam cells or glomerular segmental lesions were found.
Electron microscopy revealed a thickened glomerular basement mem-
brane with splitting and splintering of the lamina densa.
A diagnosis of hereditary nephritis was made, based on the following
data. (1) The 20-year-old sister of the patient had end-stage renal failure
necessitating regular hemodialysis, and she subsequently received a
cadaveric renal transplant. (2) Both the patient and her sister had
bilateral perceptive deafness, bilateral anterior lenticonus, and retinal
perimacular changes. No other member of the kindred was affected
(Fig. 1). The parents were first-degree cousins.
At age 21, the patient became pregnant. The nephrotic syndrome
worsened and renal failure developed during the pregnancy; serum
creatinine increased from 1.0 to 2.3 mg/dl. Blood pressure did not
increase. She delivered a 2.7 kg boy at 41 weeks gestation. Subsequent-
ly her renal function decreased progressively. At age 26, regular
hemodialysis was initiated, and at age 29 she received a cadaveric renal
transplant. One year later, creatinine clearance was 87 ml/min; no
proteinuria was found. The patient's child is now 8 years old and has no
urinary symptoms.
Patient 2. A 35-year-old man was referred for evaluation of hyperten-
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DR. JEAN-PIERRE GRUNFELD (Département de Néphro/ogie,
Hôpital Necker, Paris, France): Various heredofamilial dis-
eases involve the kidney (Table 1). The first two groups in Table
1 consist of disorders in which the renal disease is the predomi-
nant feature of the illness. Groups 3 and 4 are more heteroge-
neous diseases that affect several organs, including the kidneys.
Group 5 comprises isolated and poorly classified cases of
hereditary renal diseases [1—4]. In my experience, the frequen-
cy of hereditary renal disease is often underestimated: many
cases are undetected or unreported because they lack either
specific extrarenal defects or renal pathologic changes. Indeed,
Waldherr, who focused attention on familial diseases with
prominent glomerular involvement, found lesions compatible
with familial glomerular disease in 7% of adults with glomerular
lesions on renal biopsy specimens and in 13% of patients with
end-stage renal failure secondary to glomerulonephritis [51.
The list in Table I is not all-inclusive. I have omitted renal
diseases in which familial aggregation can occur, such as IgA
mesangial glomerulopathy (Berger's disease), lupus nephritis,
and vesicoureteral reflux complicated by renal scarring. The
discussion today will concern itself with the first group in Table
1, that is, hereditary nephritis, and most particularly, progres-
sive hereditary nephritis. Both case presentations illustrate
many features of these syndromes.
The existence of hereditary or familial renal diseases was
recognized at the end of the 19th century. In 1927, Alport
extended the study of a family that first had been investigated
by others in 1902. His report drew attention to the syndrome of
hereditary nephritis and perceptive deafness that now bears his
name [6]. In 1968 the original family was retraced, but no new
cases had appeared since Alport's report [7]. As stated by
Crawfurd and Toghill, "Alport's original family has rid itself of
Alport's disease" [7]!
The following definitions have evolved and will be useful in
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Fig. 1. Pedigree of Family 1. Symbols are: Li consanguineous
marriage; / propositus; affected female; affected male; • neural
hearing loss; ( ) age at death or "renal death."
discussing these heredofamilial disorders. (1) Alport's syn-
drome is characterized by renal disease that progresses to renal
failure and by neural hearing loss in the patient or other family
members. (2) Hereditary nephritis without nerve deafness is
characterized only by progressive renal disease in the patient or
other family members [8]; diagnosis of this disease is difficult in
the absence of a strong family history. (3) Familial benign
hematuria is characterized by renal disease without renal fail-
ure; nerve deafness is absent in the patient and other family
members. Only a few kindreds with this disorder have been
reported [9—13]. As I will discuss later, the specificity and
independence of these syndromes are not totally established,
but these definitions provide a convenient clinical classification
for analyzing these conditions.
Clinical presentation of A/port's syndrome
Renal symptoms. As noted even in the first description of this
disease, hematuria is the most frequent initial symptom in
children [6, 14]. Hematuria is either microscopic or gross,
recurrent or not. It can appear at birth or within the first few
months of life [151. Of 58 affected children reported by Gubler et
al, manifestations appeared during the first year of life in 8, 32
children had gross hematuria, and in 25 the first episode
occurred before the age of 5. Gross hematuria recurred in 26 but
usually disappeared after age 15 [15]. Gross hematuria is quite
infrequent in adults, but microscopic hematuria persists and red
blood cell casts are frequent [16]. Proteinuria is usually absent
or minimal in young children but it increases with age. The
nephrotic syndrome develops in 30% to 40% of the patients [15,
17]; its incidence peaks between ages 14 and 20.
Although pyuria was thought to be a frequent manifestation
in the large family with Alport's syndrome described by Perkoff
and colleagues [181, subsequent observations failed to confirm
this finding. It appears that in this series and in some other
series, leukocyturia did not accurately identify cases of the
disease. In particular, unaffected females frequently were erro-
neously diagnosed as having hereditary nephritis. O'Neill,
Atkin, and Bloomer restudied the kindred originally investigat-
ed by Perkoff and concluded that affected persons typically did
not have isolated pyuria (or, incidentally, isolated proteinuria)
[16].
The renal disease is progressive, leading to renal failure in at
least some members of the affected kindreds. End-stage renal
disease (ESRD) is uncommon before age 15. In the study by
Gubler et al that I referred to before, 3 boys developed ESRD
before age 9, and 5 other boys developed ESRD between ages 9
and 16 [15]. In adults, ESRD develops between ages 20 and 40
[17, 19] but can appear even after age 50. I will discuss later the
various rates of progression to ESRD. Alport's syndrome
represents approximately 3% of the causes of ESRD in the
periodic European Dialysis and Transplantation Registry re-
ports. In Utah, approximately 5% of all male patients with
ESRD were considered to have hereditary nephritis [16].
Hearing loss. Nerve deafness is one of the hallmarks of
Alport's syndrome. The neurogenic hearing impairment is
bilateral and may lead either to clinically evident deafness or to
a mild defect predominating in the middle or high tone range.
Because subclinical hearing impairment may exist, audiometric
testing is required to detect all affected individuals. Audiometry
rarely has been performed in all members of affected kindreds,
and for this reason the true incidence of neural hearing loss is
not known. We do know, however, that hearing loss varies
from one kindred to another.
The hearing defect often can be detected before age 10 [15].
Its frequency is high, at least in boys. In the pediatric series of
Gubler et al [15], 34 of 42 boys had hearing defects, whereas
only 3 of 16 girls had hearing loss. In children, serial audiome-
tric tests may show progressive hearing loss, necessitating a
hearing aid [15, 201. In contrast, hearing impairment generally
does not progress in adults. Although hearing improvement has
been described after successful renal transplantation [21], this
change may be nonspecific because deafness attributable to
uremia also may improve after renal transplantation [22].
The pathologic lesions responsible for the hearing defect are
not well delineated. Although some investigators have identi-
fied a variety of lesions [23], others have not found any
significant changes. Johnsson and Arenberg detected abnormal-
ities of the temporal bones, strial atrophy, vacuolation of the
spiral ligament, and a predominance of sensory cell degenera-
tion [24]. These abnormalities are not specific, however. It
should be noted that strial atrophy is commonly associated with
sensorineural degeneration, such as that occurring in various
forms of hereditary deafness and in noise exposure. In addition,
early childhood deafness is a common feature in a great variety
of hereditary syndromes, only some of which include renal
involvement [25—32].
Ocular defects. Ocular disorders, first described by Sohar in
1956 [33], mainly involve the lens. Bilateral anterior lenticonus
has been considered the most specific eye abnormality in
Alport' s syndrome [34]. Although microspherophakia was the
lesion first described [331, later histologic examination showed
the disorder to be bilateral anterior lenticonus [35]. Anterior
lenticonus predominates in males [15, 34] but occasionally
occurs in females as well [17]. It is always associated with
sensorineural hearing loss [171 but is less frequent than is the
hearing defect [15]. Anterior lenticonus usually is associated
with gradual deterioration of vision with the development of
axial myopia. Lens opacities have been observed in Alport's
syndrome, but their specificity is uncertain.
Recently attention has focused on the macular and perimacu-
lar changes in Alport's syndrome [15, 36, 37]. The bright,
whitish, dot-like lesions are located in the perimacular regions
of both eyes, involving the more superficial layer of the retina.
Fluorescein angiography is normal; visual acuity is preserved,
except in cases complicated by other ocular abnormalities [37].
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Fig. 2. Pedigree of Family 2. (See legend to Fig. 1.)
Slash denotes family members no longer living; dia-
mond denotes number of siblings of unknown sex; dot
within symbol denotes obligate asymptomatic carrier
of Alport's syndrome.
In some children, disappearance of the foveolar reflex is the
only abnormality that can be identified in the fundus [15]. The
changes in macular structure and pigmentation were reported
by Purriel et al in their large series [38], as well as by others in
isolated instances [37]. These changes frequently, but not
always, accompany bilateral anterior lenticonus [371.
Other extrarenal defects. Several other extrarenal abnormali-
ties have been described in Alport's syndrome [15, 19]. Hyper-
prolinemia and hyperaminoaciduria have been reported in a few
kindreds with hereditary or familial nephritis, including some
with nerve deafness [15, 19, 20]. In some of these families,
urinary tract and neurologic abnormalities also were found.
This association might be coincidental, because hyperproline-
mia is associated with several heterogeneous anomalies [151.
In contrast, platelet disorders are significantly associated
with Alport's syndrome. The association of hereditary macro-
thrombocytopathia, nephritis, and deafness was first reported
by Epstein et al in 1972 [391, and other kindreds were subse-
quently investigated. Thrombocytopenia and giant platelets
sometimes are accompanied by an in-vitro defect in platelet
function [15, 401. The May-Hegglin anomaly (megathrombocy-
topenia and white blood cell cytoplasmic inclusions, termed
Döhle bodies) has been found in one family with progressive
nephritis without nerve deafness [401.
Serum antithyroid antibodies were detected in 2 Japanese
families with Alport's syndrome, both in subjects with renal
disease as well as in some with normal urinalyses [411. In other
series, the search for antithyroid antibodies has been negative
[42; personal observations], except in one study [421 and in one
of our patients, an adult female with hereditary nephritis,
thrombocytopenia, and giant platelets, in whom we found a
high titer of antithyroid antibodies. Her affected son had been
reported previously by Gubler et al [151. Simon et al reported
antithyroid antibodies and selective serum IgA deficiency in a
male patient with renal disease, neural hearing loss, and anteri-
or lenticonus, without a positive family history [43]. The
significance of the platelet and antithyroid antibody abnormali-
ties is uncertain.
Renal histopathologic changes
For many years, renal pathologic lesions in Alport's syn-
drome were considered nonspecific. The kidney appears nor-
Table 1. Heredofamilial diseases with renal involvement in adults
1. Hereditary nephritis
Progressive hereditary nephritis
With nerve deafness (Alport's syndrome)
Without hearing impairment
Variants
Familial benign hematuria
2. Polycystic kidney disease
Adult type
Medullary cystic disease (or nephronophthisis)
3. Hereditary metabolic disorders
Diabetes mellitus
Fabry's disease
Lecithin cholesterol acyltransferase deficiency
Primary hyperoxaluria
Familial urate nephropathy
Wilson's disease
Adult-type cystinosis
Other identified or unidentified storage diseases
Various complement defects
Genetic amyloidosis (including familial
Mediterranean fever and Muckle-Wells syndrome)
Sickle-cell disease
4. Extrarenal defects (in the absence of detected
metabolic abnormalities)
Nail-patella syndrome
Hereditary osteolysis
Juvenile megaloblastic anemia (Imerslund-
Gräsbeck syndrome)
Familial dysautonomia
AlstrOm' s syndrome
Laurence-Moon-Bardet-Biedl syndrome
5. Unclassified
mal by light microscopy in young children. In older patients
with overt disease, the lesions were described as "mixed
nephritis" [441, combining interstitial fibrosis, tubular atrophy,
foam cells, and segmental proliferative glomerular changes.
Immunofluorescence study is generally negative, with the ex-
ception of scattered deposition of C3 in glomeruli or at their
vascular poles in some cases [15]. Glomerular IgA [45] or IgG
deposits may be detected in patients with heredofamilial nephri-
tis with or without nerve deafness, but this finding is the
exception [46; personal data].
In 1972, three groups of pathologists independently drew
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Table 2. Distribution of GBM ultrastructural changes in the various
forms of hereditary nephritis
Hereditary
Alport's
syndrome
nephritis
without
deafness
Benign
familial
hematuria
Nerve deafnessa +b 0 0
Renal failurea + + 0
GBM
Normal + (rare) + ?
Thick + + 0
Thin and thick d + 0
Thin + (exceptional) + +
a In the propositus or the family.
h + denotes "presence."
Common in adults.
d Common in children.
attention to a definite ultrastructural lesion of the glomerular
basement membrane (GBM) in hereditary nephritis [47—49].
The GBM is irregularly thickened, up to 4 or 5 times normal
thickness. The lamina densa is distorted and split into a
heterogeneous network of strands enclosing electron-lucent
areas. In some cases these areas contain small granulations
approximately 50 nm in diameter. Some investigators found the
tubular basement membranes to be normal or nonspecifically
involved [47, 501; others asserted that splitting of Bowman's
capsule and of the tubular basement membranes resembled, at
least in its early stages, the changes in the GBM [49]. With the
experience obtained from electron microscopy, pathologists
also gained the ability to recognize thickening of the glomerular
capillary walls by light microscopy [36], thus confirming previ-
ous observations by Kaufman et al, who emphasized that GBM
thickening was the earliest and most frequent change in heredo-
familial nephritis [511.
Subsequent studies revealed that the ultrastructural pattern
was more complex than initially conceived (Table 2). The GBM
lesions can be patchy, alternating with segments of normal
thickness. Reports of serial renal biopsies reveal that the lesions
may be absent on the first biopsy and appear subsequently [52],
or become more extensive [47]. In children, the most common
ultrastructural picture is focal thickening and extreme thinning
of the GBM [15, 53, 54]; thinning is prominent in younger
children, whereas thickening and splitting are more prevalent in
older patients.
The GBM changes recently have attracted renewed interest
among nephrologists, and I will explore these alterations in
some detail. Several questions have been raised with regard to
the universality and specificity of the GBM changes in the
various forms of hereditary nephritis.
(I) Are GBM thickening and splitting found in all patients
with Alport's syndrome? In our series, these lesions are present
in 80% of patients [36]. However, among 60 cases of hereditary
nephritis studied by electron microscopy [36], we have reported
10 fulfilling the clinical criteria of Alport's syndrome, with
either widespread thinning (15 cases) or even normal GBM (5
cases).
(2) Are the GBM changes characteristic of Alport's syn-
drome? Both GBM thickening and splitting are highly sugges-
tive of Alport's syndrome when the changes are diffuse and
when the immunofluorescent studies are negative [15, 17, 36,
47, 55, 56]. Segmental areas of GBM splitting can be found in
other renal diseases, however [53]. These GBM changes also
have been observed in kindreds with progressive hereditary
nephritis (HN) without nerve deafness [16, 52, 57]. In other
families with the same clinical entity, a normal GBM was found
by electron microscopy [17, 55]. We need further data to
estimate the relative frequency of normal and abnormal GBM in
this type of hereditary nephritis. The similarity in renal ultra-
structure between Alport's syndrome and hereditary nephritis
without nerve deafness underlines the nosologic conundrum
referred to before. It is apparent that a more specific definition
of these disorders is needed. Hereditary nephritis without nerve
deafness is probably closely related to Alport's syndrome: both
disorders have similar clinical findings, including greater sever-
ity in males than in females [8], both syndromes share a similar
deficiency in affected sons in the offspring of affected males
[19], and both show heterogeneity in ultrastructural findings. In
addition, GBM thinning has long been considered characteristic
of benign familial hematuria [13, 57, 58], the hereditary disorder
characterized by lack of progression to renal failure and lack of
hearing impairment. As I noted previously, subsequent studies
have shown that thin GBM also can occur in Alport's syndrome
[15, 53, 54, 57, 591, especially in children, in whom it represents
the prominent ultrastructural lesion [15]. Thus, the finding of
thin GBM in children should not be taken as conclusive
evidence that the patient has benign familial hematuria and that
the prognosis will be good (Table 2). The best prognostic
information can be gleaned from the family history, but careful
follow-up is needed in all cases. In this regard, the classification
of some families as having hereditary nephritis without nerve
deafness or benign familial hematuria is uncertain [11].
(3) Is electron microscopy reliable for classification and
diagnosis of persistent hematuria? Several investigators recent-
ly have claimed that the study of renal ultrastructure is useful in
evaluating children with persistent microscopic hematuria.
Among 76 children investigated by Trachtman et al [60], 26 had
GBM changes, including 9 with GBM thinning. Thickening of
the GBM was the most prevalent lesion in the subgroup with
gross hematuria [60]. Similarly, Yum and Bergstein noted that
all patients with GBM thickening and splitting had episodes of
gross hematuria [61]. Gubler and coworkers have elaborated
more precise data on the clinical relevance of electron micro-
scopic study (personal communication). Thirty of 50 children
with persistent hematuria manifested normal glomeruli by light
microscopy, no igA deposits by immunofluorescence, and
extensive GBM changes by electron microscopy. These GBM
alterations were characterized by an irregular sequence of thick
and thin segments. Repeated clinical and familial investigation
revealed at least one criterion for Alport's syndrome or heredi-
tary nephritis in 26 of these 30 children. Thus, one can conclude
that persistent hematuria in children in the absence of IgA
deposits by immunofluorescence is a major indication for
electron microscopic study of renal biopsy specimens.
The clinical usefulness of ultrastructural study is exemplified
in a 10-year-old girl, studied by Gubler et al (personal communi-
cation), who had ultrastructural changes of the GBM highly
suggestive of Alport's syndrome, but who had no extrarenal
defects and no family history of renal disease or deafness.
Eleven years later, she gave birth to a girl who developed
Hereditary nephritis 87
Table 3. Anti-GBM antibody binding in patients with hereditary
nephritis
n
Alport's
syndrome
GBM
lesion
Anti-GBM
binding
McCoy et al (1976) 8 Yes + 0 (6M)
Wilson (1980) + (2F)
McCoy et al (1982)
Olson et al (1980) 7 ? + (6)
- (1)b
0 (5M, 2F)
Jenis et al (1981) 9 No + 0 (2M, 2F)
+ (5F)
Noel et al (1981) 6 Yes + + (4M)
+ (2F)
Wilson, O'Neill ? ? ? + All but
et al (1982) one
(unpublished data)
Jeraj et al (1983) 9 Yes (7) + (7) 0 (7M)
+ (2F)
a Refers to presence of ultrastructural GBM lesion.
Refers to absence of ultrastructural GBM lesion.
hematuria at age 2. Two years later, the mother developed renal
failure and hypertension. This example demonstrates the value
of electron microscopic study in suggesting the diagnosis of
hereditary nephritis long before the family history becomes
evident. The value of electron microscopy also is supported by
Hinglais et al, who reported 2 patients with hearing and/or
ocular defects and GBM changes but whose family histories
were negative [47].
(4) Are GBM changes homogeneous in affected families? In
most families, the GBM lesions are homogeneous. When pre-
sent, they were found in all affected subjects; when absent, they
were absent in all [47, 62]. However, intrafamilial differences,
although rare, were reported in 3 kindreds investigated by
Habib et al [36] and Yoshikawa et al [57], and in one family with
hereditary nephritis without nerve deafness studied by Beath-
ard and Granhoim [52]. The question therefore remains open as
to whether GBM thickening is characteristic of a particular type
of hereditary nephritis, or whether it indicates a progressive
form of nephritis within a given family, as suggested by
Beathard and Granholm [52]. To assess the significance of the
GBM lesion, we need adequate follow-up in the families with
differences, as well as electron microscopic study in asymptom-
atic female carriers, to determine whether these individuals
have the characteristic ultrastructural changes of the GBM.
Pathogenesis of GBM lesions. It has been hypothesized that
altered composition and/or metabolism of GBM collagen is
present in Alport's syndrome. A similar defect might account
for extrarenal changes, involving collagenous structures of the
inner ear and lens capsule [63—651. A similar hypothesis has
been put forward in other diseases, such as Alström's syndrome
[29]. The results obtained by Martinez-Hernandez and Amenta
supported this hypothesis: they found that in Alport's syn-
drome, epidermal and vascular basement membranes in the
skin had the same multilamellated appearance as did the GBM,
and that they also had an abnormal distribution of laminin and
type-IV collagen antigens [66]. These authors also suggested
that the epithelial and endothelial basement membranes failed
to fuse in Alport's syndrome, resulting in the apparent splitting.
With P. Mahieu and J. -M. Foidart, we found a decrease in the
content of collagenous polypeptides and hydroxyproline of the
GBM in 4 patients with Alport's syndrome [36]. Similar changes
were found by DiBona [641. Others reported abnormalities in
urinary excretion of various collagenous or noncollagenous
GBM-related components [36, 67]. Using indirect immunofluo-
rescence, Noel et al tested antibodies directed against collage-
nous and noncollagenous components of basement membranes.
Identical fixation was found in normal kidneys and in kidneys
from patients with Alport's syndrome [68]. In another study,
the monoclonal antibody MBM4, known to be reactive with
type-IV collagen, reacted with GBM of patients with hereditary
nephritis [69]. Similarities between GBM and anterior lens
capsule have been underscored [36]: for example, monoclonal
antibodies against type-IV collagen react with anterior lens
capsule but not with posterior lens capsule, both of which are
basement membranes that contain type-IV collagen and laminin
[66].
Studies on the antigenicity of the GBM by indirect immuno-
fluorescence are still inconsistent but raise the possibility that
the biochemical changes result from a defective antigen con-
trolled by one or more genes. Most studies revealed no binding
of human anti-GBM antibodies to glomeruli of male patients
with Alport's syndrome or hereditary nephritis without nerve
deafness, whereas binding was detected in some affected fe-
males [69—7 1] (Table 3). In contrast, all patients studied reacted
as did normals with heterologous [69, 71, 72] and monoclonal
[69] anti-GBM antibodies. It was suggested that the lack of
binding reflected the absence of GBM antigen(s) and was
correlated with the severity of the GBM ultrastructural lesion
[70], but binding was also absent in one patient who had no
GBM thickening and splitting [73]. In contrast with the preced-
ing results, Noel et al found glomerular binding of antihuman
GBM antibodies in all 6 renal specimens tested [68]. Similarly,
Wilson, O'Neill et al detected antigens reactive with the panel
of antihuman GBM antibodies in all but one of the Utah patients
[71]. Therefore, only subsets of patients with hereditary nephri-
tis lack an antigen in the GBM that is present in normal kidneys.
In addition, McCoy and Wilson et al performed more detailed
immunologic investigation [71, 72]. They showed that absorp-
tion of human anti-GBM sera with GBM preparation from a
patient with Alport's syndrome did not abolish binding proper-
ties, whereas absorption with normal GBM did. Binding also
was lacking along Bowman's capsule and tubular basement
membrane (TBM) when anti-GBM sera with additional anti-
TBM reactivity were used [71]. Gubler et al have suggested that
the abnormal persistence of neonatal (or fetal) GBM lacking
GBM antigen(s) is responsible for thin GBM with irregularities,
ruptures, and repairs, leading finally to focal thickening [15].
However, the lack of GBM antigen(s) in neonates and infants
has been challenged [65].
Further investigation of GBM antigenicity using large panels
of anti-GBM antibodies is needed in families with hereditary
nephritis. From these preliminary results, some authors have
suggested that gene(s) controlling the defective antigen were
localized on the X chromosome [69, 70], some of the data being
compatible with an X-linked mode of transmission. According
to this hypothesis, hemizygous males would lack the GBM
antigen(s) completely. In heterozygous females, random inacti-
vation of a lesser or greater proportion of X chromosomes could
result in a wide range of antigen(s) defects and in a wide
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Total number
Alport's syndrome
Hereditary
nephritis
without nerve
deafness
Neural hearing
loss in the
propositus
Gross hematuria
a Age at renal failure.
b Present age.
Table 5. Renal ultrastructural changes in females with hereditary
nephritis
Thin GBM
Normal GBM
Segmental
thickening
Diffuse
thickening 6
a Age at onset of renal failure.
b Present age.
Patients
Patients with renal without
failure renal failure
45 >30h
spectrum of clinical manifestations. However, male-to-male
transmission (Fig. 2) is not compatible with an X-linked trait.
In keeping with the hypothesis of "missing" GBM antigen(s),
one might expect to observe anti-GBM antibodies and possibly
glomerulonephritis in some patients who received a renal
transplant containing normal GBM antigens. Renal transplanta-
tion has been performed in several hundred patients with
Alport's syndrome [74], and one group reported satisfactorily
functioning transplants in 10 of 11 patients [74]. Four patients
with Alport's syndrome, however, developed linear IgG
glomerular deposits and crescentic proliferative glomerulone-
phritis after renal transplantation, and serum anti-GBM anti-
bodies were found in 2 of these patients [71, 74]. In one patient,
anti-GBM immunization recurred after a second transplant,
whereas it did not recur in another [74]. In two cases (including
that studied by Wilson, O'Neill et al) [71], it was demonstrated
by immunofluorescence that the native kidneys were lacking
the GBM antigen(s). Although unproved, the "missing" GBM
antigen hypothesis remains attractive.
Prognosis
Sex. The prognosis is poorest in affected males; they typically
develop ESRD between ages 15 and 40. As noted before,
however, ESRD can develop later, after age 50 (Fig. 2). Chazan
et al reported a unique family with nonprogressive renal disease
and nerve deafness. A 57-year-old deaf male had renal involve-
ment and normal renal function, and no member of the family
had developed progressive renal failure [75].
It is well known that the renal prognosis is much less severe
in affected females than in males. There is, however, a wide
clinical spectrum of renal involvement in women, and the
prognosis may be difficult to predict in some affected females.
At one end of the spectrum are asymptomatic female carriers.
Numerous female carriers have intermittent or slight urinary
abnormalities and never develop significant renal impairment.
At the other end of the spectrum are females with progressive
nephritis that leads to ESRD when the women are between 15
and 30 years of age, as in males. In some kindreds, several
female siblings all were affected by progressive nephritis (Fig.
1) [17, 76, 77].
The rate of progression of renal disease in females is even
more heterogeneous. We recently reviewed 36 cases of heredi-
tary nephritis in women with persistent urinary abnormalities,
excluding carriers with intermittent or no urinary abnormalities
(GrUnfeld JP, Noel LH, Hafez S, unpublished data). These
patients were divided into 3 groups on the basis of renal
function and the age by which they had developed renal failure
(Table 4): (1) Nine females developed renal failure at 35 years of
age or less. In all but 2 the diagnosis of Alport's syndrome was
made; 4 had neural hearing loss. (2) Five women developed
renal failure at 45 years of age or more; all 5 had nerve deafness.
(3) The remaining 22 females, ranging from age 19 to 48 at last
follow-up, so far have normal renal function. Four have neural
hearing loss. Fourteen are presently over 30 years of age. Seven
belong to families with Alport's syndrome, and the other 7 have
hereditary nephritis without nerve deafness. In the kindred
studied by Alport [6] and further reported by Crawfurd and
Toghill [7], the renal course was quite heterogeneous among
affected women: 2 females with nephritis died at ages 69 and 83;
the first had nerve deafness. In contrast, 3 other affected
females died at ages 12, 22, and 24.
We attempted to determine the factors that predict a poor
renal prognosis by comparing female patients who developed
early or late renal failure with those who are older than 30 and
who have normal renal function. Obviously, some of the latter
group may subsequently develop renal failure. From our data,
the following indicators of poor renal prognosis emerged: gross
hematuria in childhood, neural hearing loss, Alport's syndrome
in the family (versus progressive hereditary nephritis without
nerve deafness), and presence of diffuse thickening and splitting
of the GBM by electron microscopy (Table 5). Further follow-
up is required to test the value of these indices. Additional
information is needed on the GBM ultrastructural changes in
women with late renal failure. Renal biopsy was performed in
only one of these 5 women and the GBM appeared normal
(Table 5), whereas it was thickened and split in her affected son
who developed ESRD at age 17. In 3 of the other 4 women
belonging to this group, the GBM was thickened and distorted
in at least one member of the family. Thus, GBM thickening and
splitting is commonly found in females with early renal failure,
but so far we cannot conclude whether females with late renal
failure have abnormal GBM.
Heavy proteinuria and nephrotic syndrome. We have
stressed the poor renal prognosis of patients with heavy pro-
teinuria or nephrotic syndrome in hereditary nephritis [171. The
incidence of the nephrotic syndrome is higher in patients who
progress to renal failure in childhood or in early adulthood than
Table 4. Clinical data in females with hereditary nephritis
Patients with
renal failure
Patients without
renal failure
s35a 45a >30" 28 yrs"
9 5 14 8
7 5 7 7
2 0 7
4 5 4 1
6 3 0 3
1
3
3
Hereditary nephritis 89
in those who develop renal functional impairment later (unpub-
lished data).
Hearing and ocular defects. Hearing loss augurs a poor
prognosis in males. Progression of hearing impairment in chil-
dren suggests a poor renal prognosis [151. However, males with
normal hearing may progress to renal failure (Fig. 2), both in
families with Alport's syndrome and in those with hereditary
nephritis without nerve deafness. Deaf males without renal
involvement are claimed to transmit the deleterious gene to
their offspring [14]. There is, however, no good evidence for
such a transmission if the data available in the literature are
carefully analyzed. Perkoff et al reported that deaf males with
normal urinalysis had transmitted the disease [181. Indeed, a
few of these men's daughters were considered to be affected.
As noted earlier, however, leukocyturia in these reports was
considered an indicator of renal disease, a concept rebutted by
O'Neill et al, who studied the same kindred at a later time [16].
Similarly, the data by Purriel et al are not convincing in this
regard [38]. Five males had isolated deafness, but no evidence
indicates that they had transmitted the renal disease. In another
family, one son had "intermittent proteinuria," a poor index of
hereditary renal involvement [38]. Mulrow et a! reported a deaf
male (111-12) with a normal urinalysis who had a 5-year-old
daughter with renal disease [78]. Again, these authors consid-
ered the children to be affected if they had more than 5 white
cells per high-power field. In our experience, we have not found
a deaf male with a normal urinalysis who is an unequivocal
carrier. This constellation of findings was not demonstrated in
the family of cases 7 and 8 we reported in 1972 [47], nor in the
family reported by Gubler et al [15] (personal communication).
The only possible example is in "Family 5" studied by Cassady
et al [791.
The prognostic value of the hearing defect is not as clear in
females as it is in males. Deaf female carriers with slight renal
impairment or normal renal function have been reported [6].
Deaf females may have a slow progression to renal failure. On
the whole, deaf females have a worse renal prognosis than do
thoe who are not deaf [19].
I have indicated that the presence of anterior lenticonus [17]
and perimacular changes [37] correlates with poor renal progno-
sis. However, both lesions predominate in males and are
strongly associated with deafness. The association of deafness
and anterior lenticonus in males or in females is indicative of
poor renal prognosis (Fig. 1). No instance of a carrier with an
isolated ocular defect and a normal urinalysis has been reported
so far.
Thickening and splitting of the GBM. I suggested that the
presence of this ultrastructural GBM lesion in a family indicated
a more progressive nephritis, compared with families in whom
such a lesion was not detected [17]. Mean age at death was
approximately 27 years in families with, versus 37 years in
those without, these GBM lesions. I should point out, however,
that the former mainly had Alport's syndrome, whereas the
latter kindreds all had hereditary nephritis without nerve deaf-
ness [17]. Our recent data on females also suggest that some
prognostic value may be ascribed to the GBM lesion. As I have
emphasized, male sex, deafness, anterior lenticonus, perimacu-
lar changes, and GBM thickening indicate a poor prognosis.
However, female sex and the absence of deafness, ocular
defects, and GBM lesions do not preclude the progression of
nephritis to renal failure [37].
Genetic data. I will not review all the genetic observations
and debates concerning the mode(s) of transmission of heredi-
tary nephritis [36]. 1 will focus only on the information that is
useful for renal prognosis. Tishler and Rosner noted that ages at
death or "renal death" of affected males were most often highly
concordant within affected families. From the data available,
they differentiated two groups of pedigrees. In most, age at
death in males fell between 16 and 28 years; in contrast, in 10
families, age at death was distinctly higher, ranging from 33.5 to
52.5 years (Fig. 2) [801. These results may be relevant for
predicting outcome in affected males. The clinical course in
some affected males in certain families has been highly atypical
[80], however, and obviously these conclusions do not apply to
affected females. The conclusions by Gubler vary with those of
Tishler and Rosner. Gubler's group found that the rate of
progression to renal failure varied greatly not only among
families, but even within families between successive genera-
tions. The mean age at death was 17.4 years in the study
patients, whereas it was 33.1 years in their ascendants [15].
Such a phenomenon of anticipation" was not found by Tishler
and Rosner [8t]. It may be restricted to pediatric series,
composed of children with the most severe courses, who
progress to ESRD early. This phenomenon, however, may be
observed in other kindreds (Fig. 2). In addition, Gubler et al
underlined the good concordance in the evolution of renal
failure among siblings (Figs. 1 and 2) [15].
Good evidence suggests genetic heterogeneity in Alport's
syndrome [36, 80], and this finding is consistent among patients
with GBM thickening [36]. The kindreds presented in Figures 1
and 2 illustrate this point well (Family 1 has already been
reported [17]). In the first kindred with familial nephritis (Fig.
1), recessive autosomal inheritance is suggested; the disease
appeared after a consanguineous marriage, the parents were
unaffected, and both affected women have renal and extrarenal
features highly suggestive of Alport's syndrome. Family 2 (Fig.
2) represents an example of male-to-male transmission of
Alport's syndrome, which previously has been observed, albeit
infrequently [17, 50, 55, 81], and which points to an autosomal
dominant trait. Lastly, it has been proposed that in many
kindreds the transmission of hereditary nephritis is compatible
with an X-linked trait [16, 81, 82].
Genetic theory, as well as genetic counseling, must take into
account the greater severity of Alport's syndrome in males than
in females, and the anomalous proportions of normal and
affected offspring, most particularly, the significant excess of
unaffected sons in the offspring of affected males. In addition,
we found that in affected males inheritance from the mother is
associated with a worse prognosis than is inheritance from the
father [17].
Some confusion regarding genetic conclusions may originate
from the lack of adequate markers of various types of heredi-
tary nephritis. Clinical identification of affected subjects must
rest on appropriate criteria, particularly the results of a careful-
ly performed urinalysis. A proper diagnosis is most critical and
difficult to make in some females. Relying on the reports of
large families with many severely affected subjects may intro-
duce bias in genetic analysis and counseling. There is a substan-
tial prevalence of hearing abnormalities in the general popula-
tion, so that hearing loss alone is not a good clinical marker.
The identification of the ultrastructural lesions of the GBM is
clinically helpful, but the results of electron microscopic study
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have not yet clarified the classification of the various forms of
hereditary nephritis. Yet to be developed are adequate bio-
chemical markers that identify the individual with a defective
gene.
Questions and answers
DR. KASSIRER: I am struck by the remarkable differences in
the renal manifestations of patients with hereditary nephritis.
Some patients have insignificant proteinuria, even by quantita-
tive techniques, and others have overt nephrotic syndrome. Is
there a correlation between these clinical findings and the
histopathology?
DR. GRUNFELD: As you know, it is difficult to perform
quantitative studies on electron microscopy data. We attempted
to quantify the lesions, but it is a difficult task. Perhaps Dr.
Gubler would like to comment on this point.
DR. MARIE-CLAIRE GUBLER (Maître de Recherche, INSERM
Unite 192, Hôpital des Enfants Malades, Paris): Most of our
observations have been made in children aged 2 to 16. In young
children with only hematuria, extensive thinning of the glomer-
ular basement membrane is present. In older children with
abundant proteinuria, the GBM tends to be thickened. Thus
there is some correlation, but I did not perform quantitative
measurements of the GBM.
DR. EBERHARD RITZ (Chief, Division of Nephrology, Univer-
sity of Heidelberg, Heidelberg, Federal Republic of Germany):
You pointed out that the frequency of familial nephritis as a
cause of renal disease is underestimated, sometimes for person-
al reasons. In an analysis of our patient population, Dr.
Waldherr and I found that 13% of all patients with glomerular
nephritis in our unit had a positive familial history, but only 50%
of these had classic Alport's syndrome [5]. These observations
confirm your assertion that the magnitude of the problem is
underestimated.
I also might comment on the occurrence of patients who
appear to have Alport's syndrome but who have a negative
family history of renal disease. In the report of the transplanta-
tion teams in Munich and Copenhagen, at least 10% of the
individuals reported to be the father cannot possibly be the true
father on genetic grounds. So I think this introduces a large
margin of error and underlines the Roman proverb, "Certa,
semper incertus."
DR. GRUNFELD: Je répondrai en Francais que les épouses
francaises sont au-dessus de tout soupcon.
DR. DAVID MCCARRON (Division of Nephrology and Hyper-
tension, Department of Medicine, Oregon Health Sciences
University, Portland, Oregon): When this type of inheritance is
encountered, we should suspect that environmental factors
might be playing a role in these families. In other words, a
disease could appear to be familial in transmission but actually
might be caused by familial exposure to a common environmen-
tal pathogen that results in glomerulonephritis and interstitial
disease. Do we know anything about the effects of environmen-
tal conditions?
DR. GRUNFELD: Environmental factors can affect the rate of
progression, but transmission in several successive genera-
tions, as in the family studied by Alport [6], strongly indicates a
genetic disease.
DR. ALBERT FOURNIER (Chief, Division of Nephrology,
Hôpital d'Amiens, Amiens, France): What genetic advice do
you give? Should it be different for affected males and females?
DR. GRUNFELD: Genetic counseling is not easy. The first step
is collecting adequate clinical information to determine the
mode of transmission in a given family. As I discussed earlier,
this mode can differ from one family to another. The second
step is adapting genetic counseling according to the type of
inheritance, if this can be determined. In addition, it should be
recalled that affected males have a low risk of transmission to
sons, but they have a substantial risk of transmission to
daughters whose renal disease is often, but not always, benign.
In contrast, affected female patients, or even carriers, can
transmit the disease to sons who often are severely affected.
DR. RENÉE HABIB (Directeur de Recherche, INSERM, Unite
192, Hôpital des Enfants Malades, Paris): I wonder whether we
have an adequate definition of what is and what is not Alport's
syndrome. Would you be comfortable diagnosing Alport's
syndrome in a family in whom ultrastructural studies show no
GBM changes? Wouldn't you question the diagnosis of Alport's
syndrome if you found no changes in the GBM? Perhaps the
characteristic diffuse changes of the GBM should be considered
diagnostic of Alport's syndrome whether the patient is deaf or
not, whether there is hematuria or not, and even if no other
signs of the disease are present.
DR. GRUNFELD: This issue is a difficult one. Several years
ago we reported a few patients with Alport's syndrome who did
not have the characteristic GBM changes [361. It is possible that
the GBM changes are characteristic of a certain type of
hereditary nephritis. We need additional histologic data in
families with hereditary nephritis without nerve deafness.
Eventually we may be able to better define varieties of heredi-
tary nephritis with or without GBM changes. Such studies may
disclose a new entity, independent of deafness.
DR. HABIB: Unfortunately, we find many forms of hereditary
nephritis. I think we should use the terms "Alport's syn-
drome," perhaps "with" and "without deafness." Maybe there
are variants of Alport's syndrome, but I think that the term
"hereditary nephritis" is too broad.
DR. GUBLER: I have some experience with the GBM changes
in hereditary nephritis without deafness [83]. In biopsy speci-
mens from 6 children, the GBM was thin in all. But, Yo-
shikawa, Cameron, and White observed either thin or thick
GBM in patients with hereditary nephritis without deafness [56,
57]. So the status of the GBM in this disorder awaits further
clarification.
DR. JACQUES CHANARD (Chief, Division of Nephrology,
Hôpital Maison Blanche, Reims, France): We have been look-
ing for biochemical abnormalities in the urine of patients with
Alport's disease. We measured the urinary excretion of 3- and
4-hydroxyproline. Glomerular basement membrane collagen
contains on average 8 to 12 residues of 3-hydroxyproline per
1000 residues. In 5 male patients with progressive hereditary
nephritis, we have found normal urinary excretion, contrary to
our observations in patients with polycystic renal disease [84].
DR. GRUNFELD: Your results are interesting. With Philippe
Mahieu and Jean-Michel Foidart we found a decrease in the
hydroxyproline content of the GBM in Alport's syndrome [36].
DR. CLAUDE BARBANEL (Chief, Division of Nephrology,
Hopital de Meaux, Meaux, France): Have you observed fam-
ilies with platelet abnormalities?
DR. GRUNFELD: As I recall, you described a family with the
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May-Hegglin abnormality including megathrombocytopenia
and leukocyte inclusions [40]. Although we have not encoun-
tered a similar family, Michel Broyer, Marie-Claire Gubler, and
Renée Habib found one family with a platelet defect [15]. The
mother had both a platelet defect and high titers of antithyroid
antibodies. These findings appear to be isolated instances and
do not seem to provide specific insights.
DR. KASSIRER: Can we prevent progression of renal insuffi-
ciency in such patients after renal function begins to decline? Is
transplantation or dialysis the only hope for a patient with this
disease?
DR. GRUNFELD: I hope that the future will bring us some way
of slowing the rate of progression of renal failure. Hypertension
must be controlled as in other patients. Brenner has suggested
that the propensity for young males with hereditary nephritis to
develop progressive renal disease might be due in part to the
renotrophic effects of androgenic hormones, and he also has
proposed that low protein intake might reduce the rate of
progression of chronic renal failure [85, 86].
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